H1N1 News and Research

RSS

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

The Department of Health is offering free H1N1 flu vaccines and other resources for remaining healthy at its exhibit at the Pennsylvania Farm Show, which runs through Jan. 16.

12 Jan 2010

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

The American Lung Association supports the Centers for Disease Control and Prevention's (CDC) National Influenza Vaccination Week (NIVW), January 10-16, 2010, which highlights the importance of annual influenza vaccination after the holiday season into January and beyond.

12 Jan 2010

Official H1N1-related death count approaches 13,000 worldwide, WHO says

H1N1 (swine flu) has killed 12,799 people worldwide since the virus first emerged, the WHO said on Friday, United Press International reports (1/8). According to the WHO, more than half of the H1N1-related deaths worldwide occurred in the Americas, China Daily reports (1/9).

12 Jan 2010

BioCryst Pharmaceuticals signs agreements with two additional partners

BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.

12 Jan 2010

Molina Healthcare announces preliminary results of fourth-quarter ended December 31, 2009

Molina Healthcare, Inc. announced today that, based on its preliminary unaudited analysis, it expects to report a loss per diluted share for the fourth quarter of 2009 in the range of $0.10 to $0.25, and earnings for the year ended December 31, 2009, in the range of $1.12 to $1.26.

12 Jan 2010

Los Angeles International Airport offers H1N1 flu shots in airline terminals

Los Angeles International Airport (LAX), in partnership with FLU*Ease, Inc., is now offering flu shots to travelers in most of the airline terminals as a public safety measure against the flu, especially the H1N1 strain.)

11 Jan 2010

Highmark joins with CDC to promote National Influenza Vaccination Week

Beginning Sunday, Jan. 10 and continuing through the week, Highmark Inc. will join with the Centers for Disease Control (CDC) to promote National Influenza Vaccination Week.

10 Jan 2010

Gilbert Hospital remains one of the best choices for hospital care in the southeast valley

Gilbert Hospital continued to exceed expectations in 2009. With more than 43,190 patient visits through the emergency department, patient levels remained constant compared to 2008.

9 Jan 2010

The Jean Coutu Group reports financial results for third-quarter of fiscal year 2010

The Jean Coutu Group (PJC) Inc. (the "Company" or the "Jean Coutu Group") reported its financial results today for the third quarter of fiscal year 2010 ended November 28, 2009.

9 Jan 2010

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

SeraCare Life Sciences, Inc. announced today that the Company has added five new, differentiated products to its portfolio to meet the needs of SeraCare’s growing customer base in the life sciences industry.

9 Jan 2010

Americans encouraged to get H1N1 flu vaccine during National Influenza Vaccination Week

The U.S. Department of Health and Human Services (HHS) and its Centers for Disease Control and Prevention (CDC) announced a nationwide effort to encourage more Americans to get the H1N1 flu vaccine during National Influenza Vaccination Week, January 10–16, 2010.

9 Jan 2010

Green Cross seeks regulatory approval for peramivir in S.Korea

BioCryst Pharmaceuticals, Inc. today announced that it has been informed by its partner, Green Cross Corp., that Green Cross has filed a New Drug Application (NDA) in South Korea to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza.

9 Jan 2010

CDC encourages public to receive H1N1 vaccine; PBS examines arrival of vaccine in developing countries

During a media briefing Thursday, Anne Schuchat, director of the National Center for Immunization and Respiratory Diseases at the CDC, warned against complacency over the H1N1 (swine flu), and encouraged Americans who had not yet received the H1N1 vaccine to do so, CNN reports.

8 Jan 2010

Centene announces financial guidance for the year 2010

Centene Corporation announced today its 2010 financial guidance. As previously disclosed in our December 10, 2009 press release, the discussions below reflect anticipated start-up costs associated with the new Mississippi contract, announced pharmacy carve-outs in Indiana and Ohio, and the impact of January 2010 rate changes; but do not reflect the potential impact of federal healthcare reform.

8 Jan 2010

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Lessons learned from the first 13 children at Johns Hopkins Children's Center to become critically ill from the H1N1 virus show that although all patients survived, serious complications developed quickly, unpredictably, with great variations from patient to patient and with serious need for vigilant monitoring and quick treatment adjustments.

8 Jan 2010

Business leaders should continue to monitor H1N1 risk management to alleviate major impact on costs and revenues

The swine flu pandemic may be off the media’s radar screen, but business executives can ill afford to rest easy. Experts from the National Center for Critical Incident Analysis (NCCIA), who have studied how to respond to pandemics and bioterrorism attacks, warn that executives need to continue to monitor and manage unknown risk factors that might cause the flu to have a major impact upon costs and revenues.

8 Jan 2010

H1N1 can spread during commercial flights; avoid economy and fly first class, UCLA researchers say

Viruses love plane travel. They get to fly around the world inside a closed container while their infected carrier breathes and coughs, spreading pathogens to other passengers, either by direct contact or through the air. And once people deplane, the virus can spread to other geographical areas.

8 Jan 2010

LSUHSC receives $2.1 million grant for pneumonia research

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to further his work on a discovery that plays a critical role in the body's defense against pneumonia.

8 Jan 2010

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.

8 Jan 2010

HHS releases nation’s first comprehensive strategy to address existing and emerging health threats

HHS Secretary Kathleen Sebelius today released The National Health Security Strategy, the nation’s first comprehensive strategy focused on protecting people’s health during a large-scale emergency. The strategy sets priorities for government and non-government activities over the next four years.

8 Jan 2010

H1N1 News and Research

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

Official H1N1-related death count approaches 13,000 worldwide, WHO says

BioCryst Pharmaceuticals signs agreements with two additional partners

Molina Healthcare announces preliminary results of fourth-quarter ended December 31, 2009

Los Angeles International Airport offers H1N1 flu shots in airline terminals

Highmark joins with CDC to promote National Influenza Vaccination Week

Gilbert Hospital remains one of the best choices for hospital care in the southeast valley

The Jean Coutu Group reports financial results for third-quarter of fiscal year 2010

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

Americans encouraged to get H1N1 flu vaccine during National Influenza Vaccination Week

Green Cross seeks regulatory approval for peramivir in S.Korea

CDC encourages public to receive H1N1 vaccine; PBS examines arrival of vaccine in developing countries

Centene announces financial guidance for the year 2010

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Business leaders should continue to monitor H1N1 risk management to alleviate major impact on costs and revenues

H1N1 can spread during commercial flights; avoid economy and fly first class, UCLA researchers say

LSUHSC receives $2.1 million grant for pneumonia research

Initiation of double blind placebo controlled multi-center trial of DAS181 announced

HHS releases nation’s first comprehensive strategy to address existing and emerging health threats

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News